1. Home
  2. TMCI vs SEER Comparison

TMCI vs SEER Comparison

Compare TMCI & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$4.21

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$2.09

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMCI
SEER
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
97.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TMCI
SEER
Price
$4.21
$2.09
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$4.77
N/A
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.40
EPS
N/A
N/A
Revenue
$212,690,000.00
$16,578,000.00
Revenue This Year
N/A
$2.14
Revenue Next Year
$8.18
$25.90
P/E Ratio
N/A
N/A
Revenue Growth
1.59
16.99
52 Week Low
$1.17
$1.55
52 Week High
$7.78
$2.41

Technical Indicators

Market Signals
Indicator
TMCI
SEER
Relative Strength Index (RSI) 51.65 59.16
Support Level $3.84 $1.70
Resistance Level $4.62 $2.09
Average True Range (ATR) 0.34 0.07
MACD -0.07 0.01
Stochastic Oscillator 33.33 67.73

Price Performance

Historical Comparison
TMCI
SEER

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: